Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

51.3K
Overview
51.3K
Development of Immunocompetence01:22

Development of Immunocompetence

795
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
795
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.9K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.9K
Prevalence and Incidence01:08

Prevalence and Incidence

1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Retraction Note: Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study.

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry·2026
Same author

Vaccine uptake in the context of mandate announcement and removal: Evidence from Europe and North America.

Vaccine·2026
Same author

Mpox disease epidemiology, vaccine uptake and vaccination coverage in Australia 2022-2024: a descriptive study.

EClinicalMedicine·2026
Same author

Annual immunisation coverage report 2024.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2024 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same author

ATAGI 2025 Annual Statement on Immunisation.

Communicable diseases intelligence (2018)·2026
Same journal

Measles epidemiology in Australia: 2014 to 2024. Erratum to 10.33321/cdi.2026.50.016.

Communicable diseases intelligence (2018)·2026
Same journal

Presymptomatic transmission, vaccine breakthrough and anonymous contacts: a cluster of mpox in Canberra, Australian Capital Territory, 2024.

Communicable diseases intelligence (2018)·2026
Same journal

The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026-2030.

Communicable diseases intelligence (2018)·2026
Same journal

An atlas of common Salmonella serotypes from routinely notified human cases in the Northern Territory of Australia, 2005-2024.

Communicable diseases intelligence (2018)·2026
Same journal

Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
Same journal

Australian Gonococcal Surveillance Program, 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.2K

年度免疫覆盖报告2022年

Brynley Hull1, Alexandra Hendry2, Aditi Dey2

  • 1National Centre for Immunisation Research and Surveillance; The Children's Hospital at Westmead; The University of Sydney. brynley.hull@health.nsw.gov.au.

Communicable diseases intelligence (2018)
|September 9, 2025
PubMed
概括
此摘要是机器生成的。

澳大利亚儿童疫苗接种覆盖率在2022年因COVID-19大流行影响略有下降,土著儿童的下降幅度更大. 成人疫苗接种率有所增加,可能是由于报告的改善,但仍然不理想,需要进一步研究障碍和接种策略.

关键词:
原住民和托雷斯海峡岛民的疫苗接种覆盖率流感疫苗接种 流感疫苗接种疫苗接种覆盖率 疫苗接种覆盖率疫苗接种及时性 疫苗接种及时性

更多相关视频

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.8K
Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.5K

相关实验视频

Last Updated: Jan 18, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.2K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.8K
Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

2.5K

科学领域:

  • 免疫学 免疫学 免疫学
  • 公共卫生 公共卫生
  • 流行病学 流行病学

背景情况:

  • 2023年4月澳大利亚免疫登记 (AIR) 数据提供了对儿童,青少年和成人疫苗接种覆盖率的见解.
  • 该报告侧重于2022年历年和历史趋势,重点关注国家免疫计划疫苗.

研究的目的:

  • 提供疫苗接种覆盖率数据的全面分析和解释.
  • 为澳大利亚提供基于证据的免疫政策和计划开发提供信息.

主要方法:

  • 分析澳大利亚免疫注册表 (AIR) 数据.
  • 专注于在2022年为儿童,青少年和成年人提供疫苗接种范围.
  • 与前几年的比较,以确定趋势和流行病影响.

主要成果:

  • 与2021年相比,2022年儿童疫苗接种覆盖率下降了0.6-1.1个百分点,土著儿童的下降更大.
  • 青少年人乳头瘤病毒 (HPV) 和脑膜炎球菌ACWY疫苗覆盖率显示适度下降,对土著青少年的影响更大.
  • 成年人接种疫苗覆盖率,包括疹,肺炎球菌 (13vPCV) 和流感疫苗,在2022年普遍增加,可能是由于强制性AIR报告.

结论:

  • 2022年儿童和青少年接种疫苗的适度下降与COVID-19大流行影响有关,不成比例地影响了土著人口.
  • 成人疫苗接种覆盖率有所增加,但仍然低于最佳水平,强制性报告可能会提高数据的准确性.
  • 需要进一步的研究,以了解影响儿童和青少年接种疫苗的接受和获取因素.